These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11711002)

  • 21. Summaries for patients. Benefits of lowering cholesterol levels in older patients.
    Ann Intern Med; 2001 May; 134(10):S-4. PubMed ID: 11357858
    [No Abstract]   [Full Text] [Related]  

  • 22. Japan: are statins still good for everybody?
    Sirtori CR; Calabresi L
    Lancet; 2006 Sep; 368(9542):1135-6. PubMed ID: 17011926
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 24. Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs.
    Shepherd J
    Lancet; 2002 Jun; 359(9325):2271-3. PubMed ID: 12103306
    [No Abstract]   [Full Text] [Related]  

  • 25. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 26. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
    Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P
    Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of the month. The LIPID study: "long-term intervention with pravastatin in ischaemic disease"].
    Scheen AJ
    Rev Med Liege; 1999 Jan; 54(1):2-3. PubMed ID: 10081301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 31. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

  • 32. [One year after WOSCOP, what is the correct pharmacological treatment of primary hypercholesterolemia? Réflexions du Groupe de Pharmacologie Clinique de la Société Française de Cardiologie].
    Therapie; 1996; 51(6):611-4. PubMed ID: 9163995
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy.
    Boccara F; Simon T; Lacombe K; Cohen A; Laloux B; Bozec E; Durant S; Girard PM; Laurent S; Boutouyrie P
    AIDS; 2006 Nov; 20(18):2395-8. PubMed ID: 17117030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowering cholesterol with drugs and diet.
    Pedersen TR
    N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029
    [No Abstract]   [Full Text] [Related]  

  • 35. Statins for stroke prevention: disappointment and hope.
    Amarenco P; Tonkin AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modest interventions deliver significant results in cholesterol management.
    Dis Manag Advis; 2002 Nov; 8(11):173-5, 161. PubMed ID: 12506458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.